Febuxostat in the therapy of gout: from theory to practice
Gout is a chronic disease that requires permanent urate-lowering therapy. Allopurinol is the gold standard of this therapy. The novel drug febuxostat, a selective xanthine oxidase inhibitor, has been synthesized and introduced into clinical practice in the last 10 years. The paper reviews the litera...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Russo |
| Publié: |
IMA-PRESS LLC
2018-01-01
|
| Collection: | Современная ревматология |
| Sujets: | |
| Accès en ligne: | https://mrj.ima-press.net/mrj/article/view/800 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|